RxDoctor Payments Data

Nancy Windham, MD

Gynecology · Florence, SCNPI 1770584799

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.6% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 25.5% of the total. Reporting peaked in 2019 at $249 and has fallen 70.1% since, to $75 in 2023. That places this record below the midpoint for gynecology clinicians in SC, where the typical reported total is $682.

$484in general payments, 2019–2025

Across 20 payments — averaging $24.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$123
  • Daiichi Sankyo Inc.$105
  • AbbVie$69
  • Exact Sciences$39
  • Avion Pharmaceuticals$34
  • Aspira Women's Health Inc$25
  • plus $89 from 6 others

What the payments were for

  • Food & beverage$46797%
  • Education$163%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$484 in reported general payments places this provider in the 40th percentile of 39 gynecology providers in South Carolina.

See all gynecology providers in South Carolina

Medicare billing

Part B allowed, 2024
$35,959
Medicare patients
207
Services billed
339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol104$4,567
Estradiol (Twice Weekly)Estradiol18$1,212
ValacyclovirValacyclovir Hcl31$1,037
Oxybutynin Chloride23$792
Ibandronate Sodium15$768
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet12$444
Levothyroxine Sodium30$300
Tolterodine Tartrate ErTolterodine Tartrate12$278
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst20$262
Alendronate Sodium18$199
Fluconazole51$191
Medroxyprogesterone Acetate23$134

Paid to pharmacies, not to this prescriber.

Other gynecology in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →